SCHEMBL9918690

SCHEMBL9918690

N#CCC(C1=CC=CC1)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918691 0.75 PKM (0.31) —
SCHEMBL9918689 0.73 — —
SCHEMBL9152681 0.69 SLC6A3 (0.40) —
SCHEMBL9918694 0.67 P2RX7 (0.33) —
SCHEMBL9413695 0.65 NPC1 (0.37) —
SCHEMBL16388924 0.65 — —
SCHEMBL12066241 0.65 ALDH1A1 (0.39) —
SCHEMBL7868618 0.65 IDO1 (0.32) —
SCHEMBL12066288 0.64 HPGD (0.35) —
SCHEMBL3411353 0.64 ALOX15 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149662-A1 Heterocyclic Compounds as Janus Kinase Inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 2012-06-14 — — US disclosed
Send feedback